Skip to main content
. 2013 Apr;2(2):128–141. doi: 10.3978/j.issn.2218-6751.2013.03.04

Figure 2.

Figure 2

Algorithm for ALK screening in lung cancer patients. A. Selection of patients to be included in the screening, based on clinical-pathological and molecular criteria. B. Proposal for different techniques to be used in a large screening program. EGFR, Epidermal Growth Factor Receptor; PPV, positive predictive value; RT-PCR, Reverse transcription polymerase chain reaction; TN, true negative; TP, true positive.